Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The Trailblazer Award aims to support NIH-defined New and Early Stage Investigators in research programs that combine engineering and the physical sciences with life and/or biomedical sciences. It targets exploratory, developmental, proof of concept, or high risk-high impact projects, including those that are technology design-directed, discovery-driven, or hypothesis-driven. A key requirement is that proposed research approaches must not rely on extensive preliminary data. Applications may involve minimal preliminary data but should not exceed half a page or include more than one figure. Budgets for these projects are capped at $400,000 in direct costs over a maximum of three years, with no more than $200,000 in direct costs allowed in any single year. The project's scope will dictate the period, up to three years.

    Eligibility

    Organization's Location
    non dolore, cupidatat fugiat, mollit id, et aliquip, id commodo, cupidatat tempor
    Program Location
    anim ipsum ea eiusmod occaecat laborum velit velit magna reprehenderit
    Organization Type

    Submission

    Visit Apply for more information.

    Similar grants